Skip to main content
 

BioIntelliSense Recognized as the “Best Overall Medical Device Company” for 2023 in the 7th Annual MedTech Breakthrough Awards Program

BioIntelliSense Recognized as the “Best Overall Medical Device Company” for 2023 in the 7th Annual MedTech Breakthrough Awards Program

MedTech Breakthrough selects BioIntelliSense with its BioButton® multi-parameter, medical grade wearable device and advanced clinical intelligence solutions as the “2023 Best Overall Medical Device Company.” BioIntelliSense continues to deliver breakthrough clinical intelligence solutions for scalable continuous patient monitoring and tech-enabled care.

Read more here

More News

  • Ken Nelson Joins Epitel’s Board of Directors

  • Learnroll joins Innovators’ Network at American Heart Association’s Center for Health Technology & Innovation

  • AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions